According to the Zhitong Finance App, Zhongji Longevity Science (00767) announced results for the year ended December 31, 2023, with revenue of HK$64.989 million, a year-on-year decrease of 27.5%; profit attributable to company owners was HK$2,313 million, a loss of HK$904,000 for the same period last year; basic profit per share was HK$0.15 cents.

In view of the restricted trading environment and weak atmosphere in the Chinese real estate market, in order to mitigate the risk of fluctuations, the Group adopted a very cautious attitude when operating the loan business, with the exception of loans initiated through strategic partners, so the performance was lackluster. In fiscal year 2023, on the basis of the original finance-related business, the Group actively expanded the field of longevity science through a comprehensive and diversified model, and enhanced the product chain through membership and distribution channels. The company will focus on developing and expanding the longevity science business. Longevity science has great potential and can be developed into a large-scale, dynamic and sustainable business in the future.